BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 31557973)

  • 1. Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.
    Mohamed Abd El-Aziz T; Garcia Soares A; Stockand JD
    Toxins (Basel); 2019 Sep; 11(10):. PubMed ID: 31557973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From snake venom toxins to therapeutics--cardiovascular examples.
    Koh CY; Kini RM
    Toxicon; 2012 Mar; 59(4):497-506. PubMed ID: 21447352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snake venom toxins: toxicity and medicinal applications.
    Chan YS; Cheung RCF; Xia L; Wong JH; Ng TB; Chan WY
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6165-6181. PubMed ID: 27245678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro neuromuscular activity of snake venoms.
    Hodgson WC; Wickramaratna JC
    Clin Exp Pharmacol Physiol; 2002 Sep; 29(9):807-14. PubMed ID: 12165047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient analytical platform for on-line microfluidic profiling of neuroactive snake venoms towards nicotinic receptor affinity.
    Heus F; Vonk F; Otvos RA; Bruyneel B; Smit AB; Lingeman H; Richardson M; Niessen WM; Kool J
    Toxicon; 2013 Jan; 61():112-24. PubMed ID: 23159399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snake- and Spider-Venom-Derived Toxins as Lead Compounds for Drug Development.
    Lazarovici P
    Methods Mol Biol; 2020; 2068():3-26. PubMed ID: 31576520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snake Venoms in Cancer Therapy: Past, Present and Future.
    Li L; Huang J; Lin Y
    Toxins (Basel); 2018 Aug; 10(9):. PubMed ID: 30158426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of snake venom polypeptides on central nervous system.
    Osipov A; Utkin Y
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):315-28. PubMed ID: 23270323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snake venoms and the hemostatic system.
    Markland FS
    Toxicon; 1998 Dec; 36(12):1749-800. PubMed ID: 9839663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis of snake venom toxins: pharmacological insights.
    Georgieva D; Arni RK; Betzel C
    Expert Rev Proteomics; 2008 Dec; 5(6):787-97. PubMed ID: 19086859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in venomics: Modern separation techniques and mass spectrometry.
    Abd El-Aziz TM; Soares AG; Stockand JD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122352. PubMed ID: 32971366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snake Venom: From Deadly Toxins to Life-saving Therapeutics.
    Waheed H; Moin SF; Choudhary MI
    Curr Med Chem; 2017; 24(17):1874-1891. PubMed ID: 28578650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive agents from snake venoms.
    Joseph R; Pahari S; Hodgson WC; Kini RM
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):437-59. PubMed ID: 15578962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake Venom, A Natural Library of New Potential Therapeutic Molecules: Challenges and Current Perspectives.
    Simoes-Silva R; Alfonso J; Gomez A; Holanda RJ; Sobrinho JC; Zaqueo KD; Moreira-Dill LS; Kayano AM; Grabner FP; da Silva SL; Almeida JR; Stabeli RG; Zuliani JP; Soares AM
    Curr Pharm Biotechnol; 2018; 19(4):308-335. PubMed ID: 29929461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At-line nanofractionation with parallel mass spectrometry and bioactivity assessment for the rapid screening of thrombin and factor Xa inhibitors in snake venoms.
    Mladic M; Zietek BM; Iyer JK; Hermarij P; Niessen WM; Somsen GW; Kini RM; Kool J
    Toxicon; 2016 Feb; 110():79-89. PubMed ID: 26708656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogenetic Change in the Venom of Mexican Black-Tailed Rattlesnakes (
    Borja M; Neri-Castro E; Pérez-Morales R; Strickland JL; Ponce-López R; Parkinson CL; Espinosa-Fematt J; Sáenz-Mata J; Flores-Martínez E; Alagón A; Castañeda-Gaytán G
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30513722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic applications of snake venoms: An invaluable potential of new drug candidates.
    Diniz-Sousa R; Caldeira CADS; Pereira SS; Da Silva SL; Fernandes PA; Teixeira LMC; Zuliani JP; Soares AM
    Int J Biol Macromol; 2023 May; 238():124357. PubMed ID: 37028634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity fingerprinting of venoms using on-line microfluidic AChBP profiling.
    Slagboom J; Otvos RA; Cardoso FC; Iyer J; Visser JC; van Doodewaerd BR; McCleary RJR; Niessen WMA; Somsen GW; Lewis RJ; Kini RM; Smit AB; Casewell NR; Kool J
    Toxicon; 2018 Jun; 148():213-222. PubMed ID: 29730150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snake Venom: A Promising Source of Neurotoxins Targeting Voltage-Gated Potassium Channels.
    AlShammari AK; Abd El-Aziz TM; Al-Sabi A
    Toxins (Basel); 2023 Dec; 16(1):. PubMed ID: 38251229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From venom to drugs: a review and critical analysis of Indian snake venom toxins envisaged as anticancer drug prototypes.
    Kalita B; Saviola AJ; Mukherjee AK
    Drug Discov Today; 2021 Apr; 26(4):993-1005. PubMed ID: 33486112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.